People_

Associate Professor Megan Smith

PhD, MPH, BE

Associate Professor and Co-Lead, Cervical Cancer and HPV Stream (high-income countries)
The Daffodil Centre
Honorary Principal Research Fellow
Faculty of Medicine and Health

Websites

The Daffodil Centre

ORCID profile

Biographical details

Associate Professor Megan Smith is an epidemiologist and simulation modeller with extensive experience in policy evaluations for cervical cancer prevention, including screening and HPV vaccination. More than 10 specific policy decisions have been based on the findings of these evaluations. A/Prof Smith is a member of five national or state-level committees/ advisory groups, has given multiple invited presentations to national cervical screening program advisory groups, and authored more than 140 publications.

Research interests

Improving and optimising prevention of cervical cancer and other HPV-related cancers, with a focus on equity and efficiency.

A focus on translational research - evaluation of potential future policy options and then of how well policy changes are implemented.

Teaching and supervision

Teaching and Supervision:

PhD students: Susan Yuill, Chloe Jennett

Lecturer: Cancer Prevention and Control, 2019-2021

Online moderator: Cancer Prevention and Control, 2011-2016

Current projects

NHMRC Fellowship: Optimising and Successfully Implementing Cervical Cancer Prevention Policies (2019-2022)
Cancer Institute NSW Fellowship (top-up): Optimising and Successfully Implementing Cervical Cancer Prevention Policies (2019-2021)
NHMRC Centre of Research Excellence in Cervical Cancer Control (C4)
NHMRC grant:“It’s a gamechanger” –HPV self-collection to improve equity and participation in Australia's National Cervical Screening Program (2022-2024)
Safety Monitoring of the National Cervical Screening Program (Australian Government Department of Health contract: 2019-2022).
NHMRC project grant: HPV and oropharyngeal cancer in Indigenous Australians (2017-2021).
NCSP independent monitoring group and modelling for the New Zealand NCSP (New Zealand Ministry of Health contract: 2010-2022).
US National Institutes of Health (NIH) grant: Comparative modelling to inform cervical cancer control policies - CISNET Cervix (2020-2024)
Compass trial
COVID and Cancer Global Modelling Consortium (CCGMC): working group 2 (screening)
STakeholders Opinions of Renewal Implementation and Experiences Study (STORIES)

Associations

Chair:

- Cancer Council Australia Cervix/HPV portfolio group

Member:

- NSW Cervical Screening Program Advisory Committee

- National Cervical Screening Program Guidelines Working Party

- Cancer Council Australia Cancer Screening and Immunisation Subcommittee

- BreastScreen Victoria Research Assessment Committee

Previous member (committees that have concluded):

- National Cervical Screening Program Self-Collection Expert Advisory Group

- New Zealand National Cervical Screening Programme COVID Impact Monitoring Recovery Group

- National Pathology Accreditation Advisory Committee (NPAAC) Cervical Screening Technical Drafting Committee

Themes

Cancer

Keywords

Cancer, Epidemiology, Gynaecological cancer, Head and neck cancer, Health policy

Approaches

Economics, Epidemiology, Prevention & Control

International links

Canada	(Universite Laval) Multiple collaborative projects
Ireland	(Trinity College) COVID and Cancer Global Modelling Consortium (CCGMC)
Japan	(University of Hokkaido) Multiple collaborative projects including COVID and Cancer Global Modelling Consortium (CCGMC); NHMRC Centre of Research Excellence in Cervical Cancer Control (C4)
Netherlands	(Erasmus MC) CISNET-Cervix; COVID and Cancer Global Modelling Consortium (CCGMC).
New Zealand	(New Zealand Ministry of Health) Ongoing work supporting the National Cervical Screening Programme in New Zealand, including advisory group positions.
New Zealand	(Victoria University of Wellington) Jointly authored a review article on eliminating cervical cancer among Indigenous women.
Norway	(University of Oslo) COVID and Cancer Global Modelling Consortium (CCGMC)
Slovenia	(Institute of Oncology, Ljubljana) Invited presentations and workshops for ZORA (Slovenian Cervical Screening Program)
United Kingdom	(Kings College London) Multiple collaborative projects including COVID and Cancer Global Modelling Consortium (CCGMC); Compass-PLUS
United States	(Harvard) CISNET-Cervix; COVID and Cancer Global Modelling Consortium (CCGMC)
United States	(National Cancer Institute) CISNET-Cervix
United States	(University of Minnesota) CISNET-Cervix
United States	(University of Washington) CISNET-Cervix

Current research students

Project title	Research student
Cervical screening in women with Down syndrome	Sally BYATT
The impact of individual and environmental factors on participation in the Renewed Australian National Cervical Screening Program	Chloe JENNETT

Publications

By Type

Expand all

Journals

Velentzis, L., Egger, S., Waller, J., Jennett, C., Brotherton, J., Smith, M., Bateson, D., Rogers, C., Pagotto, A., Skinner, R., Edge, R., Canfell, K., et al (2024). Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study. Preventive Medicine Reports, 45(102849). [More Information]
Yuill, S., Egger, S., Smith, M., Velentzis, L., Saville, M., Kliewer, E., Bateson, D., Canfell, K. (2024). Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study. Journal of Medical Screening, 31(1), 35-45. [More Information]
Creagh, N., Saunders, T., Brotherton, J., Hocking, J., Karahalios, A., Saville, M., Smith, M., Nightingale, C. (2024). Practitioners support and intention to adopt universal access to self-collection in Australia's National Cervical Screening Program. Cancer Medicine, 13(10). [More Information]
Velentzis, L., Smith, M., Killen, J., Brotherton, J., Guy, R., Canfell, K. (2023). A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination. eLife, 12. [More Information]
Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]
Sethi, S., Santiago, P., Soares, G., Ju, X., Antonsson, A., Canfell, K., Smith, M., Garvey, G., Hedges, J., Jamieson, L. (2023). Development and validation of an HPV infection knowledge assessment scale among Aboriginal and Torres Strait Islander Peoples. Vaccine: X, 14. [More Information]
Velentzis, L., Hawkes, D., Caruana, M., Brotherton, J., Smith, M., Roeske, L., Karim, K., Garland, S., Wrede, C., Tan, J., Canfell, K., et al (2023). Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening. Tumour Virus Research, 15. [More Information]
Ju, X., Sethi, S., Antonsson, A., Hedges, J., Canfell, K., Smith, M., Garvey, G., Logan, R., Jamieson, L. (2023). Natural History of Oral HPV Infection among Indigenous South Australians. Viruses, 15(7). [More Information]
Bavor, C., Brotherton, J., Smith, M., Prang, K., McDermott, T., Rankin, N., Zammit, C., Jennett, C., Sultana, F., Machalek, D., et al (2023). The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study. BMC Health Services Research, 23(1). [More Information]
Hedges, J., Sethi, S., Garvey, G., Whop, L., Canfell, K., Dodd, Z., Larkins, P., Antonsson, A., Smith, M., Mittinty, M., et al (2023). The Indigenous Australian Human Papillomavirus (HPV) Cohort Study 2, Continuation for 5 to 10 Years: Protocol for a Longitudinal Study. JMIR Research Protocols, 12. [More Information]
Zammit, C., Creagh, N., McDermott, T., Smith, M., Machalek, D., Jennett, C., Prang, K., Sultana, F., Nightingale, C., Rankin, N., et al (2022). "So, if she wasn't aware of it, then how would everybody else out there be aware of it?"-Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia's Cervical Screening Program: A Qualitative Study. International Journal of Environmental Research and Public Health, 19(23), 15776-1-15776-13. [More Information]
Burger, E., de Kok, I., O'mahony, J., Rebolj, M., Jansen, E., de Bondt, D., Killen, J., Hanley, S., Castanon, A., Regan, M., Canfell, K., Smith, M., et al (2022). A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions. eLife, 11. [More Information]
Yu, X., Feletto, E., Smith, M., Yuill, S., Baade, P. (2022). Cancer Incidence in Migrants in Australia: Patterns of Three Infection-Related Cancers. Cancer Epidemiology Biomarkers and Prevention, 31(7), 1394-1401. [More Information]
Vujovich-Dunn, C., Wand, H., Brotherton, J., Gidding, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Skinner, R., Davies, C., Leask, J., Canfell, K., Smith, M., Kang, M., et al (2022). Measuring school level attributable risk to support school-based HPV vaccination programs. BMC Public Health, 22(1), 822. [More Information]
Smith, M., Sherrah, M., Sultana, F., Castle, P., Arbyn, M., Gertig, D., Caruana, M., Wrede, C., Saville, M., Canfell, K. (2022). National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study. BMJ, 376, e068582-1-e068582-14. [More Information]
Hedges, J., Garvey, G., Ju, X., Canfell, K., Howard, K., Smith, M., Jamieson, L. (2022). Reflections from field notes: An oral human papillomavirus infection and oropharyngeal cancer study among Indigenous Australians. Australian Journal of Rural Health, 30(2), 286-290. [More Information]
Sethi, S., Ali, A., Ju, X., Antonsson, A., Logan, R., Canfell, K., Smith, M., Garvey, G., Hedges, J., Jamieson, L. (2021). A systematic review and meta-analysis of the prevalence of human papillomavirus infection in Indigenous populations – A Global Picture. Journal Of Oral Pathology and Medicine, 50(9), 843-854. [More Information]
Whop, L., Smith, M., Butleri, T., Adcock, A., Bartholomew, K., Goodman, M., Winer, R., Milosevic, E., Lawton, B. (2021). Achieving cervical cancer elimination among Indigenous women. Preventive Medicine, 144, 106314. [More Information]
Dodd, R., Cvejic, E., Bell, K., Black, K., Bateson, D., Smith, M., Mac, O., McCaffery, K. (2021). Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study. Gynecologic Oncology, 161(1), 179-187. [More Information]
Obermair, H., Bennett, K., Brotherton, J., Smith, M., McCaffery, K., Dodd, R. (2021). Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists. Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(3), 416-423. [More Information]
Castanon, A., Rebolj, M., Burger, E., de Kok, I., Smith, M., Hanley, S., Carozzi, F., Peacock, S., O'Mahony, J. (2021). Cervical screening during the COVID-19 pandemic: optimising recovery strategies. The Lancet Public Health, 6(7), e522-e527. [More Information]
Jamieson, L., Garvey, G., Hedges, J., Leane, C., Hill, I., Brown, A., Ju, X., Sethi, S., Roder, D., Logan, R., et al (2021). Cohort profile: Indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - A prospective longitudinal cohort. BMJ Open, 11(6), e046928. [More Information]
Portnoy, A., Pedersen, K., Trogstad, L., Hansen, B., Feiring, B., Laake, I., Smith, M., Sy, S., Nygård, M., Kim, J., et al (2021). Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation. Preventive Medicine, 150, 106688. [More Information]
Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Smith, M., Winch, K., Canfell, K., Brotherton, J. (2021). Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient? Tumour Virus Research, 11, 2000216-1-2000216-6. [More Information]
Davies-Oliveira, J., Smith, M., Grover, S., Canfell, K., Crosbie, E. (2021). Eliminating Cervical Cancer: Progress and Challenges for High-income Countries. Clinical Oncology, 33(9), 550-559. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Murray, J., Canfell, K. (2021). Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. International Journal of Cancer, 149(2), 297-306. [More Information]
Dodd, R., Whop, L., Smith, M. (2021). Facilitating uptake of cervical screening among Indigenous women to achieve equitable and timely elimination of cervical cancer. The Lancet Regional Health. Western Pacific, 13, 100236. [More Information]
Ju, X., Canfell, K., Smith, M., Sethi, S., Garvey, G., Hedges, J., Logan, R., Antonsson, A., Jamieson, L. (2021). High-Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non-Indigenous and Indigenous Populations: A Systematic Review. Otolaryngology, 165(1), 23-32. [More Information]
Poirier, B., Sethi, S., Garvey, G., Hedges, J., Canfell, K., Smith, M., Ju, X., Jamieson, L. (2021). HPV vaccine: uptake and understanding among global Indigenous communities – a qualitative systematic review. BMC Public Health, 21(1), 2062. [More Information]
Kim, J., Simms, K., Killen, J., Smith, M., Burger, E., Sy, S., Regan, C., Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Medicine, 18(3), e1003534. [More Information]
Portnoy, A., Pedersen, K., Trogstad, L., Hansen, B., Feiring, B., Laake, I., Smith, M., Sy, S., Nygård, M., Kim, J., et al (2021). Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Preventive Medicine, 144, 106276. [More Information]
Burger, E., Jansen, E., Killen, J., Kok, I., Smith, M., Sy, S., Dunnewind, N., G Campos, N., Haas, J., Kobrin, S., Canfell, K., et al (2021). Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. Journal of Medical Screening, 28(2), 213-216. [More Information]
Smith, M., Burger, E., Castanon, A., de Kok, I., Hanley, S., Rebolj, M., Hall, M., Jansen, E., Killen, J., O'Farrell, X., Canfell, K., et al (2021). Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Preventive Medicine, 151, 106623. [More Information]
Ju, X., Hedges, J., Garvey, G., Smith, M., Canfell, K., Jamieson, L. (2021). Poor self-rated oral health associated with poorer general health among Indigenous Australians. BMC Public Health, 21, 424. [More Information]
Ju, X., Canfell, K., Howard, K., Garvey, G., Hedges, J., Smith, M., Jamieson, L. (2021). Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women. PloS One, 16, e0254575. [More Information]
Ju, X., Canfell, K., Howard, K., Garvey, G., Hedges, J., Smith, M., Jamieson, L. (2021). Population-based utility scores for HPV infection and oropharyngeal squamous cell carcinoma among Indigenous Australians. BMC Public Health, 21(1), 1455. [More Information]
Santiago, P., Haag, D., Macedo, D., Garvey, G., Smith, M., Canfell, K., Hedges, J., Jamieson, L. (2021). Psychometric properties of the EQ-5D-5L for aboriginal Australians: a multi-method study. Health and Quality of Life Outcomes, 19(1), 81. [More Information]
Vujovich-Dunn, C., Skinner, R., Brotherton, J., Wand, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Gidding, H., Davies, C., Leask, J., Canfell, K., Smith, M., Kang, M., et al (2021). School-level variation in coverage of co-administered dtpa and hpv dose 1 in three australian states. Vaccines, 9(10), 1202. [More Information]
Canfell, K., Smith, M., Bateson, D. (2021). Self-collection for HPV screening: a game changer in the elimination of cervical cancer. Medical Journal of Australia, 215(8), 347-348. [More Information]
Yuill, S., Velentzis, L., Smith, M., Egger, S., Wrede, C., Bateson, D., Arbyn, M., Canfell, K. (2021). The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes. Human Vaccines and Immunotherapeutics, 17(10), 3562-3576. [More Information]
Sethi, S., Poirier, B., Canfell, K., Smith, M., Garvey, G., Hedges, J., Ju, X., Jamieson, L. (2021). Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: A qualitative systematic review. BMJ Open, 11(6), e050113. [More Information]
Burger, E., de Kok, I., Groene, E., Killen, J., Canfell, K., Kulasingam, S., Kuntz, K., Matthijsse, S., Regan, C., Simms, K., Smith, M., et al (2020). Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. Journal of the National Cancer Institute, 14(10), 1-9. [More Information]
Dodd, R., Nickel, B., Smith, M., Brotherton, J., McCaffery, K. (2020). Getting the timing right: Women's views on the best time to announce changes to cancer screening policy recommendations. Preventive Medicine Reports, 20, 101268. [More Information]
Yuill, S., Egger, S., Smith, M., Velentzis, L., Wrede, C., Bateson, D., Canfell, K. (2020). Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia. The Journal of Infectious Diseases, 222(3), 499-508. [More Information]
Simms, K., Yuill, S., Killen, J., Smith, M., Kulasingam, S., de Kok, I., van Ballegooijen, M., Burger, E., Regan, C., Kim, J., Canfell, K. (2020). Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology, 158(3), 710-718. [More Information]
Feletto, E., Grogan, P., Nickson, C., Smith, M., Canfell, K. (2020). How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. Public Health Research and Practice, 30(4), e3042026. [More Information]
Smith, M., Saville, A., Canfell, K. (2020). HPV swab self-collection and cervical cancer in women who have sex with women. Medical Journal of Australia, 213(5), 239-239.e1. [More Information]
Brisson, M., Kim, J., Canfell, K., Drolet, M., Gingras, G., Burger, E., Martin, D., Simms, K., Bénard, É., Boily, M., Keane, A., Caruana, M., Nguyen, D., Smith, M., et al (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 575-590. [More Information]
Simms, K., Hanley, S., Smith, M., Keane, A., Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public Health, 5(4), e223-e234. [More Information]
Canfell, K., Kim, J., Brisson, M., Keane, A., Simms, K., Caruana, M., Burger, E., Martin, D., Nguyen, D., Bénard, É., Smith, M., et al (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591-603. [More Information]
Jamieson, L., Antonsson, A., Garvey, G., Ju, X., Smith, M., Logan, R., Johnson, N., Hedges, J., Sethi, S., Dunbar, T., Canfell, K., et al (2020). Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults. JAMA Network Open, 3(6), e204951. [More Information]
Burger, E., Smith, M., Killen, J., Sy, S., Simms, K., Canfell, K., Kim, J. (2020). Projected time to elimination of cervical cancer in the USA: a comparative modelling study. The Lancet Public Health, 5(4), e213-e222. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Canfell, K., Murray, J. (2020). The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study. PloS One, 15(5), e0231388. [More Information]
Brotherton, J., Hawkes, D., Sultana, F., Malloy, M., Machalek, D., Smith, M., Garland, S., Saville, M. (2019). Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact. Vaccine, 37(3), 412-416. [More Information]
Simms, K., Smith, M., Caruana, M., Canfell, K. (2019). An HBV booster shot at age 10 could be cost-saving: but is it too soon to tell? International Journal of Infectious Diseases, 78, 128-129. [More Information]
Hall, M., Smith, M., Brotherton, J., Simms, K., Canfell, K. (2019). Cancer elimination thresholds: one size does not fit all - Authors' reply. The Lancet Public Health, 4(2), e87. [More Information]
Canfell, K., Kim, J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J., Campos, N., Jennett, C., Sharma, M., Simms, K., Smith, M., et al (2019). HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research, 8, 100184. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Smith, M., Hammond, I., Saville, M. (2019). Lessons from the renewal of the national cervical screening program in Australia. Public Health Research and Practice, 29(2), phrp2921914. [More Information]
Velentzis, L., Smith, M., Simms, K., Lew, J., Hall, M., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K., Skinner, R., Brand, A., Bateson, D., Armstrong, B., Canfell, K., et al (2019). Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology, 152(3), 465-471. [More Information]
Hall, M., Smith, M., Lew, J., O'Hallahan, J., Fentiman, G., Neal, H., Sage, M., Canfell, K. (2019). The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecologic Oncology, 152(3), 472-479. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]
Kang, Y., Smith, M., Canfell, K. (2018). Anal cancer in high-income countries: Increasing burden of disease. PloS One, 13(10), 1-20. [More Information]
Cheng, E., Weber, M., Feletto, E., Smith, M., Yu, X. (2018). Cancer burden and control in Australia: lessons learnt and challenges remaining. Annals of Cancer Epidemiology, 2(3), 1-15. [More Information]
Jamieson, L., Garvey, G., Hedges, J., Mitchell, A., Dunbar, T., Leane, C., Hill, I., Warren, K., Brown, A., Canfell, K., et al (2018). Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. Journal of Medical Internet Research, 7(6), e10503. [More Information]
Smith, M., Brotherton, J., Hammond, I., Anderson, L., Simms, K., Saville, M., Canfell, K. (2018). Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. Journal of the American Society of Cytopathology, 7(6), 336-338. [More Information]
Smith, M., Hall, M., Lew, J., Canfell, K. (2018). Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand. Vaccine, 36(42), 6314-6324. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]
Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting – Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Smith, M., Edwards, S., Canfell, K. (2017). Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985–2013 in all women and in Maori women. Cancer Causes and Control, 28(12), 1393-1404. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
Smith, M., Canfell, K. (2017). Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia. Papillomavirus Research, 3, 134-141. [More Information]
Carter, J., Hammond, I., Smith, M. (2017). The renewal of the National Cervical Screening Program. Medical Journal of Australia, 206(6), 274-274. [More Information]
Kang, Y., Smith, M., Barlow, E., Coffey, K., Hacker, N., Canfell, K. (2017). Vulvar cancer in high-income countries: Increasing burden of disease. International Journal of Cancer, 141(11), 2174-2186. [More Information]
Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Smith, M., Canfell, K. (2016). Impact of the Australian national cervical screening program in women of different ages. Medical Journal of Australia, 205(8), 359-364. [More Information]
Brisson, M., Bénard, É., Drolet, M., Bogaards, J., Baussano, I., Vänskä, S., Jit, M., Boily, M., Smith, M., Berkhof, J., et al (2016). Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. The Lancet Public Health, 1(1), e8-e17. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]
Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]
Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
Kang, Y., Lewis, H., Smith, M., Simonella, L., Neal, H., Bromhead, C., Canfell, K. (2015). Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Maori and non-Maori populations in New Zealand. BMC Infectious Diseases, 15(1), 365. [More Information]
Blakely, T., Kvizhinadze, G., Karvonen, T., Pearson, A., Smith, M., Wilson, N. (2014). Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand. Vaccine, 32(22), 2645-2656. [More Information]
Smith, M., Canfell, K. (2014). Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake. PloS One, 9(8), 1-10. [More Information]
Pearson, A., Kvizhinadze, G., Wilson, N., Smith, M., Canfell, K., Blakely, T. (2014). Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program. BMC Infectious Diseases, 14(1), 1-15. [More Information]
Smith, M., Canfell, K. (2014). Testing previous model predictions against new data on human papillomavirus vaccination program outcomes. BMC Research Notes, 7(1), 1-5. [More Information]
Smith, M. (2014). UPDATE ON HPV VACCINATION IN AUSTRALIA. Cancer Forum, 38(3), 207-208. [More Information]
Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
Simonella, L., Lewis, H., Smith, M., Neal, H., Bromhead, C., Canfell, K. (2013). Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infectious Diseases, 13(1), 1-10. [More Information]
Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]
Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]

show 100 more

Magazine / Newspaper Articles

Canfell, K., Hall, M., Simms, K., Smith, M., Saville, M. (2018). Australia on-track to be the first country to achieve cervical cancer elimination. HPV World.

Report

Smith, M., Hall, M., Simms, K., Killen, J., Sherrah, M., O’Farrell, X., Canfell, K., Grogan, P. (2020). Modelled analysis of hypothetical impacts of COVID-19 related disruptions to the National Cervical Screening Program.

Research Reports

Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.

By Year

Expand all

2024

Velentzis, L., Egger, S., Waller, J., Jennett, C., Brotherton, J., Smith, M., Bateson, D., Rogers, C., Pagotto, A., Skinner, R., Edge, R., Canfell, K., et al (2024). Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort study. Preventive Medicine Reports, 45(102849). [More Information]
Yuill, S., Egger, S., Smith, M., Velentzis, L., Saville, M., Kliewer, E., Bateson, D., Canfell, K. (2024). Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study. Journal of Medical Screening, 31(1), 35-45. [More Information]
Creagh, N., Saunders, T., Brotherton, J., Hocking, J., Karahalios, A., Saville, M., Smith, M., Nightingale, C. (2024). Practitioners support and intention to adopt universal access to self-collection in Australia's National Cervical Screening Program. Cancer Medicine, 13(10). [More Information]

2023

Velentzis, L., Smith, M., Killen, J., Brotherton, J., Guy, R., Canfell, K. (2023). A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination. eLife, 12. [More Information]
Nickson, C., Smith, M., Feletto, E., Velentzis, L., Broun, K., Deij, S., Grogan, P., Hall, M., He, E., St John, D., Lew, J., Procopio, P., Simms, K., Worthington, J., Canfell, K., et al (2023). A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia. eLife, 12. [More Information]
Sethi, S., Santiago, P., Soares, G., Ju, X., Antonsson, A., Canfell, K., Smith, M., Garvey, G., Hedges, J., Jamieson, L. (2023). Development and validation of an HPV infection knowledge assessment scale among Aboriginal and Torres Strait Islander Peoples. Vaccine: X, 14. [More Information]
Velentzis, L., Hawkes, D., Caruana, M., Brotherton, J., Smith, M., Roeske, L., Karim, K., Garland, S., Wrede, C., Tan, J., Canfell, K., et al (2023). Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening. Tumour Virus Research, 15. [More Information]
Ju, X., Sethi, S., Antonsson, A., Hedges, J., Canfell, K., Smith, M., Garvey, G., Logan, R., Jamieson, L. (2023). Natural History of Oral HPV Infection among Indigenous South Australians. Viruses, 15(7). [More Information]
Bavor, C., Brotherton, J., Smith, M., Prang, K., McDermott, T., Rankin, N., Zammit, C., Jennett, C., Sultana, F., Machalek, D., et al (2023). The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study. BMC Health Services Research, 23(1). [More Information]
Hedges, J., Sethi, S., Garvey, G., Whop, L., Canfell, K., Dodd, Z., Larkins, P., Antonsson, A., Smith, M., Mittinty, M., et al (2023). The Indigenous Australian Human Papillomavirus (HPV) Cohort Study 2, Continuation for 5 to 10 Years: Protocol for a Longitudinal Study. JMIR Research Protocols, 12. [More Information]

show 4 more

2022

Zammit, C., Creagh, N., McDermott, T., Smith, M., Machalek, D., Jennett, C., Prang, K., Sultana, F., Nightingale, C., Rankin, N., et al (2022). "So, if she wasn't aware of it, then how would everybody else out there be aware of it?"-Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia's Cervical Screening Program: A Qualitative Study. International Journal of Environmental Research and Public Health, 19(23), 15776-1-15776-13. [More Information]
Burger, E., de Kok, I., O'mahony, J., Rebolj, M., Jansen, E., de Bondt, D., Killen, J., Hanley, S., Castanon, A., Regan, M., Canfell, K., Smith, M., et al (2022). A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions. eLife, 11. [More Information]
Yu, X., Feletto, E., Smith, M., Yuill, S., Baade, P. (2022). Cancer Incidence in Migrants in Australia: Patterns of Three Infection-Related Cancers. Cancer Epidemiology Biomarkers and Prevention, 31(7), 1394-1401. [More Information]
Vujovich-Dunn, C., Wand, H., Brotherton, J., Gidding, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Skinner, R., Davies, C., Leask, J., Canfell, K., Smith, M., Kang, M., et al (2022). Measuring school level attributable risk to support school-based HPV vaccination programs. BMC Public Health, 22(1), 822. [More Information]
Smith, M., Sherrah, M., Sultana, F., Castle, P., Arbyn, M., Gertig, D., Caruana, M., Wrede, C., Saville, M., Canfell, K. (2022). National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study. BMJ, 376, e068582-1-e068582-14. [More Information]
Hedges, J., Garvey, G., Ju, X., Canfell, K., Howard, K., Smith, M., Jamieson, L. (2022). Reflections from field notes: An oral human papillomavirus infection and oropharyngeal cancer study among Indigenous Australians. Australian Journal of Rural Health, 30(2), 286-290. [More Information]

show 3 more

2021

Sethi, S., Ali, A., Ju, X., Antonsson, A., Logan, R., Canfell, K., Smith, M., Garvey, G., Hedges, J., Jamieson, L. (2021). A systematic review and meta-analysis of the prevalence of human papillomavirus infection in Indigenous populations – A Global Picture. Journal Of Oral Pathology and Medicine, 50(9), 843-854. [More Information]
Whop, L., Smith, M., Butleri, T., Adcock, A., Bartholomew, K., Goodman, M., Winer, R., Milosevic, E., Lawton, B. (2021). Achieving cervical cancer elimination among Indigenous women. Preventive Medicine, 144, 106314. [More Information]
Dodd, R., Cvejic, E., Bell, K., Black, K., Bateson, D., Smith, M., Mac, O., McCaffery, K. (2021). Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study. Gynecologic Oncology, 161(1), 179-187. [More Information]
Obermair, H., Bennett, K., Brotherton, J., Smith, M., McCaffery, K., Dodd, R. (2021). Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists. Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(3), 416-423. [More Information]
Castanon, A., Rebolj, M., Burger, E., de Kok, I., Smith, M., Hanley, S., Carozzi, F., Peacock, S., O'Mahony, J. (2021). Cervical screening during the COVID-19 pandemic: optimising recovery strategies. The Lancet Public Health, 6(7), e522-e527. [More Information]
Jamieson, L., Garvey, G., Hedges, J., Leane, C., Hill, I., Brown, A., Ju, X., Sethi, S., Roder, D., Logan, R., et al (2021). Cohort profile: Indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - A prospective longitudinal cohort. BMJ Open, 11(6), e046928. [More Information]
Portnoy, A., Pedersen, K., Trogstad, L., Hansen, B., Feiring, B., Laake, I., Smith, M., Sy, S., Nygård, M., Kim, J., et al (2021). Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation. Preventive Medicine, 150, 106688. [More Information]
Smith, M., Hall, M., Saville, M., Brotherton, J., Simms, K., Lew, J., Bateson, D., Skinner, R., Kelaher, M., Canfell, K. (2021). Could HPV testing on self-collected samples be routinely used in an organized cervical screening program? A modeled analysis. Cancer Epidemiology Biomarkers and Prevention, 30(2), 268-277. [More Information]
Smith, M., Winch, K., Canfell, K., Brotherton, J. (2021). Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient? Tumour Virus Research, 11, 2000216-1-2000216-6. [More Information]
Davies-Oliveira, J., Smith, M., Grover, S., Canfell, K., Crosbie, E. (2021). Eliminating Cervical Cancer: Progress and Challenges for High-income Countries. Clinical Oncology, 33(9), 550-559. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Murray, J., Canfell, K. (2021). Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. International Journal of Cancer, 149(2), 297-306. [More Information]
Dodd, R., Whop, L., Smith, M. (2021). Facilitating uptake of cervical screening among Indigenous women to achieve equitable and timely elimination of cervical cancer. The Lancet Regional Health. Western Pacific, 13, 100236. [More Information]
Ju, X., Canfell, K., Smith, M., Sethi, S., Garvey, G., Hedges, J., Logan, R., Antonsson, A., Jamieson, L. (2021). High-Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non-Indigenous and Indigenous Populations: A Systematic Review. Otolaryngology, 165(1), 23-32. [More Information]
Poirier, B., Sethi, S., Garvey, G., Hedges, J., Canfell, K., Smith, M., Ju, X., Jamieson, L. (2021). HPV vaccine: uptake and understanding among global Indigenous communities – a qualitative systematic review. BMC Public Health, 21(1), 2062. [More Information]
Kim, J., Simms, K., Killen, J., Smith, M., Burger, E., Sy, S., Regan, C., Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Medicine, 18(3), e1003534. [More Information]
Portnoy, A., Pedersen, K., Trogstad, L., Hansen, B., Feiring, B., Laake, I., Smith, M., Sy, S., Nygård, M., Kim, J., et al (2021). Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Preventive Medicine, 144, 106276. [More Information]
Burger, E., Jansen, E., Killen, J., Kok, I., Smith, M., Sy, S., Dunnewind, N., G Campos, N., Haas, J., Kobrin, S., Canfell, K., et al (2021). Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. Journal of Medical Screening, 28(2), 213-216. [More Information]
Smith, M., Burger, E., Castanon, A., de Kok, I., Hanley, S., Rebolj, M., Hall, M., Jansen, E., Killen, J., O'Farrell, X., Canfell, K., et al (2021). Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis. Preventive Medicine, 151, 106623. [More Information]
Ju, X., Hedges, J., Garvey, G., Smith, M., Canfell, K., Jamieson, L. (2021). Poor self-rated oral health associated with poorer general health among Indigenous Australians. BMC Public Health, 21, 424. [More Information]
Ju, X., Canfell, K., Howard, K., Garvey, G., Hedges, J., Smith, M., Jamieson, L. (2021). Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women. PloS One, 16, e0254575. [More Information]
Ju, X., Canfell, K., Howard, K., Garvey, G., Hedges, J., Smith, M., Jamieson, L. (2021). Population-based utility scores for HPV infection and oropharyngeal squamous cell carcinoma among Indigenous Australians. BMC Public Health, 21(1), 1455. [More Information]
Santiago, P., Haag, D., Macedo, D., Garvey, G., Smith, M., Canfell, K., Hedges, J., Jamieson, L. (2021). Psychometric properties of the EQ-5D-5L for aboriginal Australians: a multi-method study. Health and Quality of Life Outcomes, 19(1), 81. [More Information]
Vujovich-Dunn, C., Skinner, R., Brotherton, J., Wand, H., Sisnowski, J., Lorch, R., Veitch, M., Sheppeard, V., Effler, P., Gidding, H., Davies, C., Leask, J., Canfell, K., Smith, M., Kang, M., et al (2021). School-level variation in coverage of co-administered dtpa and hpv dose 1 in three australian states. Vaccines, 9(10), 1202. [More Information]
Canfell, K., Smith, M., Bateson, D. (2021). Self-collection for HPV screening: a game changer in the elimination of cervical cancer. Medical Journal of Australia, 215(8), 347-348. [More Information]
Yuill, S., Velentzis, L., Smith, M., Egger, S., Wrede, C., Bateson, D., Arbyn, M., Canfell, K. (2021). The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes. Human Vaccines and Immunotherapeutics, 17(10), 3562-3576. [More Information]
Sethi, S., Poirier, B., Canfell, K., Smith, M., Garvey, G., Hedges, J., Ju, X., Jamieson, L. (2021). Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: A qualitative systematic review. BMJ Open, 11(6), e050113. [More Information]

show 23 more

2020

Burger, E., de Kok, I., Groene, E., Killen, J., Canfell, K., Kulasingam, S., Kuntz, K., Matthijsse, S., Regan, C., Simms, K., Smith, M., et al (2020). Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. Journal of the National Cancer Institute, 14(10), 1-9. [More Information]
Dodd, R., Nickel, B., Smith, M., Brotherton, J., McCaffery, K. (2020). Getting the timing right: Women's views on the best time to announce changes to cancer screening policy recommendations. Preventive Medicine Reports, 20, 101268. [More Information]
Yuill, S., Egger, S., Smith, M., Velentzis, L., Wrede, C., Bateson, D., Canfell, K. (2020). Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia. The Journal of Infectious Diseases, 222(3), 499-508. [More Information]
Simms, K., Yuill, S., Killen, J., Smith, M., Kulasingam, S., de Kok, I., van Ballegooijen, M., Burger, E., Regan, C., Kim, J., Canfell, K. (2020). Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecologic Oncology, 158(3), 710-718. [More Information]
Feletto, E., Grogan, P., Nickson, C., Smith, M., Canfell, K. (2020). How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. Public Health Research and Practice, 30(4), e3042026. [More Information]
Smith, M., Saville, A., Canfell, K. (2020). HPV swab self-collection and cervical cancer in women who have sex with women. Medical Journal of Australia, 213(5), 239-239.e1. [More Information]
Brisson, M., Kim, J., Canfell, K., Drolet, M., Gingras, G., Burger, E., Martin, D., Simms, K., Bénard, É., Boily, M., Keane, A., Caruana, M., Nguyen, D., Smith, M., et al (2020). Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 575-590. [More Information]
Simms, K., Hanley, S., Smith, M., Keane, A., Canfell, K. (2020). Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. The Lancet Public Health, 5(4), e223-e234. [More Information]
Smith, M., Hall, M., Simms, K., Killen, J., Sherrah, M., O’Farrell, X., Canfell, K., Grogan, P. (2020). Modelled analysis of hypothetical impacts of COVID-19 related disruptions to the National Cervical Screening Program.
Canfell, K., Kim, J., Brisson, M., Keane, A., Simms, K., Caruana, M., Burger, E., Martin, D., Nguyen, D., Bénard, É., Smith, M., et al (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591-603. [More Information]
Jamieson, L., Antonsson, A., Garvey, G., Ju, X., Smith, M., Logan, R., Johnson, N., Hedges, J., Sethi, S., Dunbar, T., Canfell, K., et al (2020). Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults. JAMA Network Open, 3(6), e204951. [More Information]
Burger, E., Smith, M., Killen, J., Sy, S., Simms, K., Canfell, K., Kim, J. (2020). Projected time to elimination of cervical cancer in the USA: a comparative modelling study. The Lancet Public Health, 5(4), e213-e222. [More Information]
Hall, M., Smith, M., Simms, K., Barnabas, R., Canfell, K., Murray, J. (2020). The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study. PloS One, 15(5), e0231388. [More Information]

show 10 more

2019

Brotherton, J., Hawkes, D., Sultana, F., Malloy, M., Machalek, D., Smith, M., Garland, S., Saville, M. (2019). Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact. Vaccine, 37(3), 412-416. [More Information]
Simms, K., Smith, M., Caruana, M., Canfell, K. (2019). An HBV booster shot at age 10 could be cost-saving: but is it too soon to tell? International Journal of Infectious Diseases, 78, 128-129. [More Information]
Hall, M., Smith, M., Brotherton, J., Simms, K., Canfell, K. (2019). Cancer elimination thresholds: one size does not fit all - Authors' reply. The Lancet Public Health, 4(2), e87. [More Information]
Canfell, K., Kim, J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J., Campos, N., Jennett, C., Sharma, M., Simms, K., Smith, M., et al (2019). HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research, 8, 100184. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study. The Lancet Oncology, 20(3), 394-407. [More Information]
Smith, M., Hammond, I., Saville, M. (2019). Lessons from the renewal of the national cervical screening program in Australia. Public Health Research and Practice, 29(2), phrp2921914. [More Information]
Velentzis, L., Smith, M., Simms, K., Lew, J., Hall, M., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K., Skinner, R., Brand, A., Bateson, D., Armstrong, B., Canfell, K., et al (2019). Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. Gynecologic Oncology, 152(3), 465-471. [More Information]
Hall, M., Smith, M., Lew, J., O'Hallahan, J., Fentiman, G., Neal, H., Sage, M., Canfell, K. (2019). The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. Gynecologic Oncology, 152(3), 472-479. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Brotherton, J., Saville, M., Frazer, I., Canfell, K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. [More Information]
Simms, K., Steinberg, J., Caruana, M., Smith, M., Lew, J., Soerjomataram, I., Castle, P., Bray, F., Canfell, K. (2019). Towards global elimination of cervical cancer in all groups of women - Authors' reply. The Lancet Oncology, 20(5), e239. [More Information]

show 7 more

2018

Kang, Y., Smith, M., Canfell, K. (2018). Anal cancer in high-income countries: Increasing burden of disease. PloS One, 13(10), 1-20. [More Information]
Canfell, K., Hall, M., Simms, K., Smith, M., Saville, M. (2018). Australia on-track to be the first country to achieve cervical cancer elimination. HPV World.
Cheng, E., Weber, M., Feletto, E., Smith, M., Yu, X. (2018). Cancer burden and control in Australia: lessons learnt and challenges remaining. Annals of Cancer Epidemiology, 2(3), 1-15. [More Information]
Jamieson, L., Garvey, G., Hedges, J., Mitchell, A., Dunbar, T., Leane, C., Hill, I., Warren, K., Brown, A., Canfell, K., et al (2018). Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention. Journal of Medical Internet Research, 7(6), e10503. [More Information]
Smith, M., Brotherton, J., Hammond, I., Anderson, L., Simms, K., Saville, M., Canfell, K. (2018). Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. Journal of the American Society of Cytopathology, 7(6), 336-338. [More Information]
Smith, M., Hall, M., Lew, J., Canfell, K. (2018). Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand. Vaccine, 36(42), 6314-6324. [More Information]
Hall, M., Simms, K., Lew, J., Smith, M., Saville, M., Canfell, K. (2018). Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia. PloS One, 13(2), 1-19. [More Information]

show 4 more

2017

Lew, J., Simms, K., Smith, M., Saville, M., Hammond, I., Canfell, K. (2017). Cost-effectiveness estimates: the need for complete reporting – Authors' reply. The Lancet Public Health, 2(5), e212. [More Information]
Velentzis, L., Caruana, M., Simms, K., Lew, J., Shi, J., Saville, M., Smith, M., Lord, S., Tan, J., Bateson, D., Canfell, K., et al (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International Journal of Cancer, 141(12), 2410-2422. [More Information]
Smith, M., Edwards, S., Canfell, K. (2017). Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985–2013 in all women and in Maori women. Cancer Causes and Control, 28(12), 1393-1404. [More Information]
Simms, K., Hall, M., Smith, M., Lew, J., Hughes, S., Yuill, S., Hammond, I., Saville, A., Canfell, K. (2017). Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the national cervical screening program in Australia. PloS One, 12(1), 1-23. [More Information]
Lew, J., Simms, K., Smith, M., Hall, M., Kang, Y., Xu, X., Caruana, M., Velentzis, L., Bessell, T., Saville, A., Canfell, K., et al (2017). Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. The Lancet Public Health, 2(2), e96-e107. [More Information]
Smith, M., Canfell, K. (2017). Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia. Papillomavirus Research, 3, 134-141. [More Information]
Carter, J., Hammond, I., Smith, M. (2017). The renewal of the National Cervical Screening Program. Medical Journal of Australia, 206(6), 274-274. [More Information]
Kang, Y., Smith, M., Barlow, E., Coffey, K., Hacker, N., Canfell, K. (2017). Vulvar cancer in high-income countries: Increasing burden of disease. International Journal of Cancer, 141(11), 2174-2186. [More Information]

show 5 more

2016

Simms, K., Laprise, J., Smith, M., Lew, J., Caruana, M., Brisson, M., Canfell, K. (2016). Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. The Lancet Public Health, 1(2), e66-e75. [More Information]
Lew, J., Simms, K., Smith, M., Lewis, H., Neal, H., Canfell, K. (2016). Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand. PloS One, 11(5), 1-21. [More Information]
Smith, M., Lew, J., Simms, K., Canfell, K. (2016). Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program. Medical Journal of Australia, 204(5), 194.e1-194.e9. [More Information]
Smith, M., Canfell, K. (2016). Impact of the Australian national cervical screening program in women of different ages. Medical Journal of Australia, 205(8), 359-364. [More Information]
Brisson, M., Bénard, É., Drolet, M., Bogaards, J., Baussano, I., Vänskä, S., Jit, M., Boily, M., Smith, M., Berkhof, J., et al (2016). Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. The Lancet Public Health, 1(1), e8-e17. [More Information]
Smith, M., Gertig, D., Hall, M., Simms, K., Lew, J., Malloy, M., Saville, M., Canfell, K. (2016). Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC Health Services Research, 16(1), 1-14. [More Information]
Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2016). Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: Analysis of national hospital data. BMC Infectious Diseases, 16(1), 1-11. [More Information]
Simms, K., Smith, M., Lew, J., Kitchener, H., Castle, P., Canfell, K. (2016). Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries. International Journal of Cancer, 139(12), 2771-2780. [More Information]

show 5 more

2015

Smith, M., Liu, B., McIntyre, P., Menzies, R., Dey, A., Canfell, K. (2015). Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data. The Journal of Infectious Diseases, 211(1), 91-99. [More Information]
Kang, Y., Lewis, H., Smith, M., Simonella, L., Neal, H., Bromhead, C., Canfell, K. (2015). Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Maori and non-Maori populations in New Zealand. BMC Infectious Diseases, 15(1), 365. [More Information]

2014

Blakely, T., Kvizhinadze, G., Karvonen, T., Pearson, A., Smith, M., Wilson, N. (2014). Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand. Vaccine, 32(22), 2645-2656. [More Information]
Smith, M., Canfell, K. (2014). Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake. PloS One, 9(8), 1-10. [More Information]
Pearson, A., Kvizhinadze, G., Wilson, N., Smith, M., Canfell, K., Blakely, T. (2014). Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program. BMC Infectious Diseases, 14(1), 1-15. [More Information]
Smith, M., Canfell, K. (2014). Testing previous model predictions against new data on human papillomavirus vaccination program outcomes. BMC Research Notes, 7(1), 1-5. [More Information]
Smith, M. (2014). UPDATE ON HPV VACCINATION IN AUSTRALIA. Cancer Forum, 38(3), 207-208. [More Information]

show 2 more

2013

Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.
Simonella, L., Lewis, H., Smith, M., Neal, H., Bromhead, C., Canfell, K. (2013). Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infectious Diseases, 13(1), 1-10. [More Information]

2012

Walker, R., Nickson, C., Lew, J., Smith, M., Canfell, K. (2012). A revision of sexual mixing matrices in models of sexually transmitted infection. Statistics in Medicine, 31(27), 3419-3432. [More Information]
Legood, R., Smith, M., Lew, J., Walker, R., Moss, S., Kitchener, H., Patnick, J., Canfell, K. (2012). Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study. BMJ: British Medical Journal, 345, 1-10. [More Information]
Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]

2011

Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
Canfell, K., Shi, J., Lew, J., Walker, R., Zhoa, F., Simonella, L., Chen, J., Legood, R., Smith, M., Nickson, C., et al (2011). Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Vaccine, 29(13), 2487-2494. [More Information]
Smith, M., Lew, J., Walker, R., Brotherton, J., Nickson, C., Canfell, K. (2011). The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine, 29(8), 9112-9122. [More Information]

2010

Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]

2008

Smith, M., Canfell, K., Brotherton, J., Lew, J., Barnabas, R. (2008). The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer, 123(8), 1854-1863. [More Information]

Selected Grants

2023

Human Papillomavirus (HPV) Screening in VaccinatedPopulations: A Clinical and Cost-Effectiveness Model, Smith M, Health and Social Care (UK)/Research Funding

2021

Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people, Smith M, Whop L, Brotherton J, Garvey G, Wenitong M, Nightingale C, Guy R, Cunningham J, National Health and Medical Research Council (NHMRC)/Targeted Call for Research into Participation in Cancer Screening Programs 2021
THE PREVENT PROJECT, Powell A, Smith M, Department of Health and Aged Care (Federal)/Indigenous Australians Health Programme - Emerging Priorities Round 2

2018

Optimising and Successfully Implementing Cervical Cancer Prevention Policies, Smith M, National Health and Medical Research Council (NHMRC)/Early Career Fellowships

Guidelines

Saville M, Canfell K, Smith M, Brand A, Armstrong B, Hammond I, and Cancer Council Australia Cervical Cancer Screening Guidelines Working Party. National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding: Oncogenic HPV types not 16/18. Sydney: Cancer Council Australia, 2021.
Cancer Council Australia Cervical Cancer Screening Guidelines Working Party (including Smith M). National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding. Sydney: Cancer Council Australia, 2017.

Commissioned Government Reports

Published (20+ additional unpublished reports)

Health technology assessment reports

Lew JB*, Simms K,* Smith M, Kang YK, Xu X, Caruana M, Walker R and Canfell K. National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting (Assessment Report). MSAC Application No. 1276. April 2014. (*Joint first authors)
Moss S, Kelly R, Legood R, Sadique Z, Canfell K, Lew JB,Smith M, Walker R. Evaluation of Sentinel Sites for HPV Triage and Test of Cure: Report to NHS Cancer Screening Programmes.
Canfell K, Lew JB, Smith M and Walker R, Cost-effectiveness modelling beyond MAVARIC study end-points, in: HC Kitchener, R Blanks, H Cubie, M Desai, G Dunn, R Legood, A Gray, Z Sadique and S Moss, on behalf of the MAVARIC Trial Study Group. MAVARIC – a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technology Assessment 2011; 15 (3). January 2011.
Human Papillomavirus Triage Test For Women With Possible or Definite Low-Grade Squamous Intraepithelial Lesions. Report for the Medical Services Advisory Committee (MSAC Reference 39), Australia. March 2009. (Health Technology Assessors: Suzanne Dyer, Sally Lord, Sally Wortley, Kirsten Howard, Karen Canfell, Megan Smith, Jie Bin Lew, Prudence Creighton, Yoon Jung Kang, Mark Clements)
Automation Assisted and Liquid Based Cytology for Cervical Cancer Screening. Report for the Medical Services Advisory Committee (MSAC Assessment 1122), Australia. March 2009. (Health Technology Assessors: Suzanne Dyer, Sally Lord, Sally Wortley, Kirsten Howard, Karen Canfell, Megan Smith, Jie Bin Lew, Prudence Creighton, Yoon Jung Kang, Mark Clements).

Evaluation reports

Smith M, Hall M, Simms K, Killen J, Sherrah M, O’Farrell X, Grogan P, Canfell K. Modelled analysis of hypothetical impacts of COVID-19 related disruptions on the National Cervical Screening Program. Report to the Department of Health (May 2020). Available at: https://www.health.gov.au/resources/publications/modelled-analysis-of-hypothetical-impacts-of-covid-19-related-disruptions-to-the-national-cervical-screening-program
Smith M, Liu B, Canfell K, Dey A, Menzies R, McIntyre P. Chapter 6: Disease impact – Anogenital warts. In: National Centre for Immunisation Research & Surveillance. Evaluation of the National Human Papillomavirus Vaccination Program Final Report. Canberra, March 2015.
Gertig D, Smith M, Kang YJ, Canfell K, Saville M. Assessment of laboratory compliance with guideline recommendations in:Australian Institute of Health and Welfare 2013.Report on monitoring activities of the National Cervical Screening Program Safety Monitoring Committee. Cancer series 80. Cat. no. CAN 77. Canberra: AIHW.

Other reports

Smith M, Machalek D, Brotherton J, Creagh N, Bateson D, Nightingale C, Evans S, Whop L, Hawkes D, Marshall H, Garland S, Guy R, Saville M and Canfell K, on behalf of the NHMRC Centre of Research Excellence in Cervical Cancer Control. 2022 Cervical Cancer Elimination Progress Report: Australia’s progress towards the elimination of cervical cancer as a public health problem. Published online December 2022. Available at https://www.cervicalcancercontrol.org.au
Brotherton J, Machalek D, Smith M, Yuill S, Sherrah M, Whop L, Evans S, Bateson D, Marshall H, Garland S, Hawkes D, Wrede D, Guy R, Nightingale C, Kaldor J, Saville M and Canfell K. 2021 Cervical Cancer Elimination Progress Report: Australia’s progress towards the elimination of cervical cancer as a public health problem. Published online 26/3/2021, Melbourne, Australia. Available at https://www.cervicalcancercontrol.org.au
Smith M, Rumlee L, Sherrah M, Canfell K. National Cervical Screening Programme Monitoring Report Number 52 (1 July – 31 December 2019). National Screening Unit: Wellington, 2022.
Smith M, Sherrah M, Canfell K. National Cervical Screening Programme Monitoring Report Number 51 (1 January – 30 June 2019). National Screening Unit: Wellington, 2021.
Smith M, Sherrah M, Canfell K. National Cervical Screening Programme Monitoring Report Number 50 (1 July – 31 December 2018). National Screening Unit: Wellington, 2021.
Smith M, Rumlee L, Sherrah M, Canfell K. National Cervical Screening Programme Monitoring Report Number 49 (1 January – 30 June 2018). National Screening Unit: Wellington, 2020.
Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Monitoring Report 48, July - December 2017. Report for the National Screening Unit, NZ Ministry of Health. National Screening Unit: Wellington, 2019.
Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Monitoring Report 47, January - June 2017. Report for the National Screening Unit, NZ Ministry of Health. National Screening Unit: Wellington, June 2018.
Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Annual Report 2015. National Screening Unit: Wellington, June 2018.
Smith M, Rumlee L, Canfell K. NCSP Six-monthly Monitoring Report 46, July - December 2016. Report for the National Screening Unit, NZ Ministry of Health. National Screening Unit: Wellington, April 2018.
Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Annual Report 2014. National Screening Unit: Wellington, July 2017.
Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Monitoring Report Number 45 (1 January – 30 June 2016). National Screening Unit: Wellington, July 2017.
Smith M, Yap S, Rumlee L, Canfell K. NCSP Six-monthly Monitoring Report 44, July - December 2015. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2017.
Smith M, Edwards S, Rumlee L, Canfell K. NCSP Six-monthly Monitoring Report 43, January - June 2015. Report for the National Screening Unit, NZ Ministry of Health. May 2016. Wellington, March 2017.
Smith M, Edwards S, Canfell K. NCSP Annual Report 2013. Report for the National Screening Unit, NZ Ministry of Health. Wellington, April 2016.
Smith M, Edwards S, Canfell K. NCSP Six-monthly Monitoring Report 42, July - December 2014. Report for the National Screening Unit, NZ Ministry of Health. Wellington, February 2016.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 41, January - June 2014. Report for the National Screening Unit, NZ Ministry of Health. Wellington, May 2015.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 40, July - December 2013. Report for the National Screening Unit, NZ Ministry of Health. Wellington, February 2015.
Smith M, Walker R, Simms K, Canfell K. National Cervical Screening Programme Annual Report (2012). Report for the National Screening Unit, NZ Ministry of Health. Wellington, February 2015.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 39, January - June 2013. Report for the National Screening Unit, NZ Ministry of Health. Wellington, July 2014.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 38, July - December 2012. Report for the National Screening Unit, NZ Ministry of Health. Wellington, July 2014.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 37, January - June 2012. Report for the National Screening Unit, NZ Ministry of Health. Wellington, December 2013.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 36, July - December 2011. Report for the National Screening Unit, NZ Ministry of Health. Wellington, December 2013.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 35, January - June 2011. Report for the National Screening Unit, NZ Ministry of Health. Wellington, December 2013.
Smith M, Walker R, Canfell K. National Cervical Screening Programme Annual Report (2010-2011). Report for the National Screening Unit, NZ Ministry of Health. Wellington, December 2013.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 34, July - December 2009. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2012.
Smith M, Walker R, Canfell K. NCSP Six-monthly Monitoring Report 33, January - June 2010. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2012.
Smith M, Walker R, Canfell K. National Cervical Screening Programme Annual Report (2008-2009). Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2012.
Smith M, Walker R, Clements M, Canfell K. NCSP Six-monthly Monitoring Report 32, July - December 2009. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2011.
Smith M, Walker R, Clements M, Canfell K. NCSP Six-monthly Monitoring Report 31, January - June 2009. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2011.
Smith M, Walker R, Clements M, Canfell K, Lewis H, Neal H, and Maxwell A. NCSP Six-monthly Monitoring Report 30, July - December 2008. Report for the National Screening Unit, NZ Ministry of Health. Wellington, March 2011.

In the media

2017. Never had a Pap smear? Now there’s a DIY option foryou
2023. Saunders T, Nightingale C, Smith M, Bavor C. Australia on track to be the first country to eliminate cervical cancer, but inequities persist. Pursuit (University of Melbourne); republished in Medical Xpress. Published online March 2023. Available at: https://pursuit.unimelb.edu.au/articles/we-can-eliminate-cervical-cancer and https://medicalxpress.com/news/2023-03-australia-track-country-cervical-cancer.html
Bateson D, Saville M, Smith M. Q&A: supporting patients with cervical self-collection. O & G magazine. December 2022.
Smith M, Bateson D, Varlow M. Eliminating cervical cancer among all Australians. PartyLine - an online magazine of the National Rural Health Alliance. September 2022
Bateson D, Saville M,Smith M.Self-collection: equity in reaching cervical cancer elimination. MJA Insight. August 2022. Available at:https://insightplus.mja.com.au/2022/30/self-collection-equity-in-reaching-cervical-cancer-eli/

Page not found